Term ends Mar 8, 2033 · High confidence
20-year base term ends Mar 8, 2033
Held by SPR Therapeutics, Inc.
Filed Nov 19, 2014 as application 14/547,493 · Granted Jan 31, 2017
Base term, 20 years from filing
Today
2013
2033
Clock starts
Mar 8, 2013
Mar 8, 2013
Term ends
Mar 8, 2033
Mar 8, 2033
Granted
Jan 31, 2017
Jan 31, 2017
base term
fee events
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,965,516, to Mar 8, 2033. The term already ends on or before that date, so the cap shortened nothing.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 8, 2013, when application 13/791,710, the earliest non-provisional in its chain, was filed (this one was filed Nov 19, 2014) | Mar 8, 2033 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,965,516) | resolves to Mar 8, 2033, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Mar 8, 2033 | High confidence |
This family
| US 8,965,516 | In force Mar 2033 | Mar 2033 |
| US 9,555,245 | this patent Mar 2033 | Mar 2033 |
| Application 15/419,038 | Abandoned not computed | not computed |
| US 11,116,971 | In force Mar 2033 | Mar 2033 |
| US 12,036,407 | In force Mar 2033 | Mar 2033 |
| Application 18/772,597 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 19, 2014 Reel 34209, frame 743 | Boggs, Joseph W., II; Bennett, Maria E.; Wongsarnpigoon, Amorn; Chae, John; Grill, Warren M.; Stager, Kathryn; Zang, Rosemary | SPR Therapeutics, LLC | Assignment of Assignor's Interest |
| Nov 9, 2017 Reel 44715, frame 395 | SPR Therapeutics, Inc. | The Director of the Ohio Development Services Agency | Security Interest |
| Dec 6, 2017 Reel 44716, frame 812 | SPR Therapeutics, LLC | SPR Therapeutics, Inc. | Change of Name |
| Oct 15, 2019 Reel 50728, frame 721 | The Director of the Ohio Development Services Agency | SPR Therapeutics, Inc. | Release of Security Interest |
| Jan 30, 2024 Reel 66381, frame 75 | SPR Therapeutics, Inc. | SLR Investment Corp., as Agent | Intellectual Property Security Agreement |
| Jan 30, 2024 Reel 66412, frame 400 | SPR Therapeutics, Inc. | Gemino Healthcare Finance, LLC | Security Interest |
| Feb 8, 2024 Reel 66526, frame 25 | The Director of Development, State of Ohio, Formerly Known as the Director of the Ohio Development Services Agency | SPR Therapeutics, Inc., Formerly Known as SPR Therapeutics, LLC | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 374 | Gemino Healthcare Finance, LLC, D/B/A SLR Healthcare ABL | SPR Therapeutics, Inc. | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 409 | SLR Investment Corp., as Agent | SPR Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Mar 2033
Term ends Mar 8, 2033. Maintenance fees still fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 8,965,516, ends no earlier than this term, so it caps nothing.
Citations
19
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.